AstraZeneca PLC Loses $10 Billion in Value as Long-Awaited MYSTIC Trial Disappoints

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-astrazeneca.jpg" NAME"AstraZeneca PLC Loses $10 Billion in Value as Long-Awaited MYSTIC Trial Disappoints" ALT"AstraZeneca PLC Loses $10 Billion in Value as Long-Awaited MYSTIC Trial Disappoints"July 27, 2017By Alex Keown</A...…

Continue ReadingAstraZeneca PLC Loses $10 Billion in Value as Long-Awaited MYSTIC Trial Disappoints

Astellas Takes a $387 Million+ Loss as It Shuts Down SoCal's Agensys, Inc.

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-astellas.jpg" NAME"Astellas Takes a $387 Million Loss as It Shuts Down SoCal's Agensys" ALT"Astellas Takes a $387 Million Loss as It Shuts Down SoCal's Agensys"July 27, 2017By Mark Terry,…

Continue ReadingAstellas Takes a $387 Million+ Loss as It Shuts Down SoCal's Agensys, Inc.

Heads Up Startups: Silicon Valley VC Firm&mdash;With an Appetite for Biotech&mdash;Nabs Record $800 Million Fund

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-stock-positive.jpg" NAME"Heads Up Startups: Silicon Valley VC FirmWith an Appetite for BiotechNabs Record $800 Million" ALT"Heads Up Startups: Silicon Valley VC FirmWith an Appetite for BiotechNabs Record $800 Million"July…

Continue ReadingHeads Up Startups: Silicon Valley VC Firm&mdash;With an Appetite for Biotech&mdash;Nabs Record $800 Million Fund

3 Biotechs With Positive Technical Stock Readouts Ahead of Q2 Reports

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"3 Biotechs With Positive Technical Stock Readouts Ahead of Q2 Reports" ALT"3 Biotechs With Positive Technical Stock Readouts Ahead of Q2 Reports"July 26, 2017By Mark Terry, BioSpace.com Breaking…

Continue Reading3 Biotechs With Positive Technical Stock Readouts Ahead of Q2 Reports